Jinmatrix (CEO Kim Soo-ok) announced that it will be participating in the international diagnostics exhibition 'Medlab Middle East 2025' held at the Dubai World Trade Center in the United Arab Emirates until the 6th (local time) and will showcase its main products.
Medlab is a diagnostic and medical device exhibition in the Middle East and Africa, and Genematrix has been participating in Medlab for five consecutive years since 2021. According to the exhibition organizers, last year, a total of 670 million dollars in business value was created, and this year, more than 800 companies and about 20,000 industry professionals from 40 countries around the world are expected to participate.
At this exhibition, Jinmatrix will introduce a diverse lineup of high-performance multi-molecular diagnostic products, ‘NeoPlex’, including respiratory infection (RI) diagnosis, sexually transmitted infection (STI) diagnosis, human papillomavirus (HPV) diagnosis, and acute enterocolitis (GI) diagnosis. The plan is to focus on sexually transmitted infection products, including respiratory disease product groups (RI), which have recently seen an increase in exports within the region.
A representative of Jinmatrix emphasized, “This is a region that is particularly notable for respiratory infection and sexually transmitted infection products, and we plan to spur sales of related products,” and “As this is a world-class exhibition, we will focus on increasing brand awareness, expanding into the global market, and discovering new business opportunities.”
- See more related articles
You must be logged in to post a comment.